# Strata Skin Sciences Inc. (SSKN)

Source: https://www.quantisnow.com/company/SSKN
Generated: 2026-11-12T01:00:06.816Z

- Ticker: SSKN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2005
- SEC CIK: 0001051514
- Website: strataskinsciences.com

## About

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

## Latest SSKN news and filings

- 2026-07-28 13:15 UTC [Leadership Update] [STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer](https://www.quantisnow.com/insight/strata-skin-sciences-appoints-medical-device-commercial-leader-erica-jordan-6650959)
- 2026-05-18 12:30 UTC [New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo](https://www.quantisnow.com/insight/new-peer-reviewed-publication-confirms-unprecedented-response-rates-for-stratas-excimer-6559283)
- 2026-03-26 01:33 UTC [SEC Form 10-K] [SEC Form 10-K filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-strata-skin-sciences-inc-6469737)
- 2026-03-05 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-strata-skin-sciences-inc-6431217)
- 2026-03-05 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-strata-skin-sciences-inc-6431210)
- 2026-03-05 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-strata-skin-sciences-inc-6431209)
- 2026-03-02 21:30 UTC [SEC Form 15-12G filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-strata-skin-sciences-inc-6422295)
- 2026-02-27 21:04 UTC [SEC Form POS AM filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-strata-skin-sciences-inc-6418838)
- 2026-02-27 21:04 UTC [SEC Form POS AM filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-strata-skin-sciences-inc-6418826)
- 2026-02-27 21:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418810)
- 2026-02-27 21:04 UTC [SEC Form POS AM filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-strata-skin-sciences-inc-6418806)
- 2026-02-27 21:03 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418795)
- 2026-02-27 21:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418790)
- 2026-02-27 21:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418785)
- 2026-02-27 21:02 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418781)
- 2026-02-27 21:01 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418776)
- 2026-02-27 21:01 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-strata-skin-sciences-inc-6418764)
- 2026-02-19 21:05 UTC [STRATA Skin Sciences Confirms Nasdaq Delisting](https://www.quantisnow.com/insight/strata-skin-sciences-confirms-nasdaq-delisting-6402208)
- 2026-02-19 21:00 UTC [SEC Form 25 filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-strata-skin-sciences-inc-6402095)
- 2026-02-18 13:15 UTC [Johns Hopkins Dermatology Expands Advanced Care for Inflammatory and Autoimmune Skin Conditions with Addition of XTRAC® Excimer Laser](https://www.quantisnow.com/insight/johns-hopkins-dermatology-expands-advanced-care-for-inflammatory-and-autoimmune-6398371)
- 2026-02-17 13:15 UTC [STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis](https://www.quantisnow.com/insight/strata-skin-sciences-highlights-meta-analysis-confirming-clinical-efficacy-of-308-6394499)
- 2026-02-11 22:00 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-notice-of-6387231)
- 2025-12-17 21:31 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-regulation-fd-6320235)
- 2025-12-10 21:31 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-submission-of-6310833)
- 2025-12-09 13:15 UTC [STRATA Skin Sciences Showcases XTRAC® and TheraclearX® at TeraCILAD 2025 — Reports Early Adoption Momentum in Mexico](https://www.quantisnow.com/insight/strata-skin-sciences-showcases-xtrac-and-theraclearx-at-teracilad-2025-6308085)
- 2025-11-18 21:35 UTC [Insider Buy] [Director Rubinstein Samuel sold $18,804 worth of shares (14,094 units at $1.33) and bought $7,028 worth of shares (5,000 units at $1.41), decreasing direct ownership by 51% to 8,766 units (SEC Form 4)](https://www.quantisnow.com/insight/director-rubinstein-samuel-sold-18804-worth-of-shares-14094-units-6285316)
- 2025-11-14 22:25 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-strata-skin-sciences-inc-6281485)
- 2025-11-13 21:16 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-results-of-6277647)
- 2025-11-13 21:05 UTC [Public Offering] [STRATA Skin Sciences Reports Third Quarter 2025 Financial Results and Provides a Corporate Update](https://www.quantisnow.com/insight/strata-skin-sciences-reports-third-quarter-2025-financial-results-and-6277242)
- 2025-11-06 13:00 UTC [STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion](https://www.quantisnow.com/insight/strata-skin-sciences-announces-cms-recognition-of-expanded-cpt-codes-6264218)
- 2025-11-05 13:00 UTC [Earnings Date] [STRATA Skin Sciences to Report Third Quarter 2025 Financial Results on November 13, 2025 and Provide Corporate Update](https://www.quantisnow.com/insight/strata-skin-sciences-to-report-third-quarter-2025-financial-results-6261088)
- 2025-10-30 20:48 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-strata-skin-sciences-inc-6253067)
- 2025-10-28 12:00 UTC [STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear® in Mexico and First Commercial Placements](https://www.quantisnow.com/insight/strata-skin-sciences-announces-cofepris-clearance-of-theraclear-in-mexico-6247007)
- 2025-10-20 20:48 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-strata-skin-sciences-inc-6238769)
- 2025-10-20 12:00 UTC [STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek](https://www.quantisnow.com/insight/strata-skin-sciences-reinforces-market-leadership-following-key-litigation-milestones-6238114)
- 2025-10-16 20:30 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-other-events-6235874)
- 2025-10-15 20:26 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Strata Skin Sciences Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-strata-skin-sciences-inc-6234149)
- 2025-10-14 20:17 UTC [SEC Form 8-K] [Strata Skin Sciences Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/strata-skin-sciences-inc-filed-sec-form-8-k-notice-of-6232441)
- 2025-10-14 12:15 UTC [Conference Announcement] [Excimer Laser Demonstrates Promising Results in Treating Rare Variant of Cutaneous Lymphoma, Mycosis Fungoides](https://www.quantisnow.com/insight/excimer-laser-demonstrates-promising-results-in-treating-rare-variant-of-6231562)
- 2025-10-03 14:50 UTC [Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences' XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis](https://www.quantisnow.com/insight/marking-eczema-awareness-month-clinical-research-validates-strata-skin-sciences-6221955)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SSKN
- Earnings history: https://www.quantisnow.com/earnings/SSKN
- Dividend history: https://www.quantisnow.com/dividends/SSKN
- Insider transactions: https://www.quantisnow.com/insiders/SSKN
- Options chain: https://www.quantisnow.com/options/SSKN
- SEC 8-K filings only: https://www.quantisnow.com/company/SSKN/8-k
- RSS and alerts for SSKN: https://www.quantisnow.com/docs/rss-feeds.md